In a nutshell, CSI’s Q1 results and commentary essentially confirmed what we discussed last March: a solid M&A pipeline with medium and larger-sized deals, as well as typical organic growth. In other words, growing opportunities for capital deployment at healthy IRRs, with Mark Miller’s increased focus on driving organic growth where it makes sense (commensurate with good returns).